These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33932736)

  • 1. Structural insights from an in silico molecular docking simulation of complement component 3a receptor 1 with an antagonist.
    Misawa K; Sugai Y; Fujimori T; Hirokawa T
    J Mol Graph Model; 2021 Jul; 106():107914. PubMed ID: 33932736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes.
    Shen J; Zhang W; Fang H; Perkins R; Tong W; Hong H
    BMC Bioinformatics; 2013; 14 Suppl 14(Suppl 14):S6. PubMed ID: 24266910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective hexapeptide agonists and antagonists for human complement C3a receptor.
    Scully CC; Blakeney JS; Singh R; Hoang HN; Abbenante G; Reid RC; Fairlie DP
    J Med Chem; 2010 Jul; 53(13):4938-48. PubMed ID: 20527893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
    Ibrahim MAA; Abdelrahman AHM; Hassan AMA
    Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.
    Sun J; Ember JA; Chao TH; Fukuoka Y; Ye RD; Hugli TE
    Protein Sci; 1999 Nov; 8(11):2304-11. PubMed ID: 10595533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB.
    Liao S; Pino MJ; Deleon C; Lindner-Jackson M; Wu C
    Life Sci; 2022 Jul; 300():120553. PubMed ID: 35452636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some insights into the binding mechanism of the GABAA receptor: a combined docking and MM-GBSA study.
    Xie HB; Sha Y; Wang J; Cheng MS
    J Mol Model; 2013 Dec; 19(12):5489-500. PubMed ID: 24241181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds.
    Jin H; Wu C; Su R; Sun T; Li X; Guo C
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of agonist WAY-267,464 and antagonist WAY-methylated to oxytocin receptor probed by all-atom molecular dynamics simulations.
    Uba AI; Radicella C; Readmond C; Scorese N; Liao S; Liu H; Wu C
    Life Sci; 2020 Jul; 252():117643. PubMed ID: 32298738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations.
    Fan JR; Zheng QC; Cui YL; Li WK; Zhang HX
    J Biomol Struct Dyn; 2015; 33(11):2360-7. PubMed ID: 26065334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches.
    Zhu J; Li K; Xu L; Jin J
    Chem Biol Drug Des; 2019 May; 93(5):818-831. PubMed ID: 30582283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations.
    Tripathi S; Kumar A; Kumar BS; Negi AS; Sharma A
    J Biomol Struct Dyn; 2016 Jun; 34(6):1232-40. PubMed ID: 26212016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvising 5-HT
    Jha P; Chaturvedi S; Swastika ; Pal S; Jain N; Mishra AK
    J Biomol Struct Dyn; 2018 Aug; 36(10):2475-2494. PubMed ID: 28745550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.